SHENZHEN, China, May 12, 2026 /PRNewswire/ -- TCL, a leading global technology company, announced its inclusion in Forbes' 2025 list of the World's Top Companies for Women, recognizing its success in building an inclusive culture and championing women in the workplace.

To compile the list, Forbes partnered with market research firm Statista to survey approximately 120,000 women working for multinational corporations in more than 36 countries. Each company's score aggregates survey responses with a "public opinion score" that quantifies women's gender perceptions of different companies, as well as data on women in executive and board positions. The list ranks 400 corporations with a significant global presence across at least two continents.

In addition to career advancement, TCL offers family-friendly benefits such as mother and baby rooms, extended paid maternity leave and childbirth allowances, along with women's healthcare services including cancer screening and psychological counseling.

"Women's empowerment is a core component of TCL's globalization and sustainability strategy, linking our technological innovation with social development," said Wei Xue, Vice President & Chief of the ESG Office at TCL Technology Group Corporation, and Chairperson of TCL Charity Foundation. "Our inclusion on Forbes' list is a tribute to TCL's long-term commitment to empowering women in the workplace and supporting their career development. We are honored to be included and proud of our track record of creating opportunity for all people."

TCL operates in more than 160 countries and regions, engaging with local communities and respecting local cultural norms to empower women in the workplace. The company maintains its commitment to diversity and inclusion by assessing Environmental, Social and Governance indicators in its global subsidiaries and using this data to inform its employment policies.

TCL Extends Female Empowerment Mission Beyond the Workplace

Since 2018, TCL has partnered with FIBA, the world's governing body for basketball, to promote female participation in the sport. The company has supported numerous global events and will continue its involvement with the upcoming FIBA Women's World Cup in Germany in September and the 2027 FIBA World Cup in Qatar. 

Through the Huameng Foundation, a philanthropic initiative established by TCL's founders, the company funds female-focused programs that have enabled nearly 1,000 young women from underprivileged families to complete high school and tertiary studies. The Foundation uses technology to advance its charitable causes, supporting community development in China and elsewhere.

In addition, TCL's dynamic and long-running #TCLforHer campaign leverages technology, sports and education to empower young women and nurture their ambitions through a variety of community initiatives. The campaign shares stories of trailblazers who challenge assumptions and tear down boundaries, inspiring women everywhere to boldly defy stereotypes and fulfill their potential. 

#TCLforHer has received numerous international marketing honors for its storytelling prowess. In January 2025, it won a prestigious Silver Telly Award—a major prize in the global documentary and TV brand film sector—for its 2024 marketing campaign, which centers around two brand films produced by a predominantly female team. 

TCL's inclusion on the Forbes list of the World's Top Companies for Women marks an important milestone, affirming the company's leadership in female empowerment and commitment to breaking the glass ceiling for women worldwide.

About TCL

Founded in 1981, TCL—short for "The Creative Life"—embodies creativity in every aspect of life. As a leading technology brand, TCL is dedicated to delivering innovative solutions—including TVs, smartphones, audio products, smart home devices, display technologies, and clean energy—that enhance customer experiences through two independent entities—TCL Industries and TCL Technology.

With 47 R&D centers and 40 manufacturing bases globally, TCL operates in over 160 countries and regions, cementing its position as a globally competitive smart technology brand. To further inspire greatness, TCL has become an official Worldwide Olympic and Paralympic Partner in the Home Audiovisual Equipment and Home Appliances category.

Logo - https://mma.prnewswire.com/media/2748692/Picture1__1_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/forbes-names-tcl-one-of-the-worlds-top-companies-for-women-in-2025-302769218.html

Sandoz hat im ersten Quartal 2026 trotz erheblicher Verwerfungen im Penicillin-Geschäft weiteres Wachstum erzielt. Der Umsatz des Schweizer Generika- und Biosimilar-Spezialisten belief sich zwischen Januar und März auf 2,76 Milliarden US-Dollar, ein Plus von 11 Prozent gegenüber dem Vorjahreszeitraum. Zu konstanten Wechselkursen legten die Erlöse um 3 Prozent zu. Der Konzern bestätigt nach eigenen Angaben seinen Ausblick für das Gesamtjahr.

Treiber der Entwicklung war vor allem das höhermargige Biosimilar-Geschäft, das die frühere Novartis-Tochter weiter ausgebaut hat. Dagegen stand die grössere Generika-Sparte erneut unter Druck, weil sich die Marktverwerfungen im Penicillin-Segment fortsetzten. Klammerte man die negativen Auswirkungen aus dem Antibiotika-Geschäft aus, hätte das Umsatzplus zu konstanten Wechselkursen bei rund 5 Prozent gelegen und damit im Rahmen der Unternehmensprognose.

Die Belastungen resultieren aus einem anhaltenden Preisverfall bei wichtigen Penicillin-Wirkstoffen (Active Pharmaceutical Ingredients), der bereits im Vorjahr eingesetzt hatte. Hintergrund sind US-Zölle, die chinesische Anbieter dazu veranlasst haben, ihre Penicillin-Mengen verstärkt nach Europa umzuleiten. Das zusätzliche Angebot hat dort die Preise deutlich gedrückt. Parallel dazu führten in Indien eingeführte Mindestpreisvorschriften dazu, dass weniger chinesische Ware in diesen Markt floss, was den Wettbewerbsdruck in Europa zusätzlich verschärfte und den Preisdruck weiter verstärkte.

Laut Sandoz konzentrieren sich die heftigsten Auswirkungen dieser Entwicklung auf das erste Quartal, die verbleibenden Effekte sollen sich nun schrittweise abschwächen. Analysten verweisen darauf, dass das Unternehmen ohne den Antibiotika-Gegenwind im Rahmen seiner Guidance gewachsen wäre. Der Konzern bleibt damit auf Wachstumskurs, muss sich im Generika-Kerngeschäft jedoch weiterhin in einem von handelspolitischen Eingriffen und regulatorischen Änderungen verzerrten Marktumfeld behaupten.